The best white-label telehealth platforms in 2026
Nine platforms, compared on the four things that actually separate them. Written by one of them, which is disclosed throughout, with the cases where a competitor is the better answer stated plainly.
Key takeaways
- This is written by PharmaBro, a platform in the comparison. Read it as an interested party's analysis.
- Four criteria separate this category: pricing model, merchant of record, launch speed and multi-brand terms.
- Roughly half the platforms here do not publish pricing at all, which is itself a data point.
- Bask holds SOC 2 Type II and PharmaBro does not. If that is a procurement gate, Bask is the answer.
- If you want working capital carried for you, OpenLoop is a genuinely different and defensible product.
The disclosure, up front
PharmaBro publishes this page and competes with every platform on it. That is a conflict of interest and pretending otherwise would make the rest worthless.
The way to handle it is to be checkable. Every claim about a competitor below is sourced or marked as not published, PharmaBro's own numbers are on its public pricing page, and the cases where a competitor is the better choice are stated rather than omitted. If something here is wrong, the correction offer at the bottom is genuine.
The four criteria that matter
Feature lists in this category converged years ago. Every platform has intake, a portal, e-prescribing, a pharmacy network and analytics. The differences are commercial and structural.
- Pricing model. Flat fee or a percentage of your billings. This decides whether scale improves your unit economics.
- Merchant of record. Whose account receives the patient's payment, and therefore who holds the card tokens.
- Launch speed. Days versus weeks of paid traffic you cannot yet run.
- Multi-brand terms. Whether brand two needs a new contract and a new implementation fee.
The comparison
Where a field says not published, that is literal: the platform does not disclose it publicly and we are not going to guess.
| Platform | Pricing | Merchant of record | Launch | Multi-brand |
|---|---|---|---|---|
| PharmaBro | Flat, published, $1,500 to $5,000/mo | Your brand | 5 days | Unlimited |
| Cuvo | Flat, published | Cuvo | Fast | Limited by plan |
| Rimo | Flat, published | Your brand | About 5 days | Limited |
| Bask Health | Fee plus percentage | Bask | 30 to 40 days | Not published |
| OpenLoop | Fees plus share of collections | OpenLoop | 30 to 60 days | Addendum plus fee |
| CareValidate | $2,500 to $5,000/mo plus 3.9% | CareValidate (BYO on Enterprise) | 30 days | Per-category fees |
| Wheel | Revenue share | Not published | Build project | Not published |
| WhitelabelMD | Not published | Not published | Not published | Not published |
| Fuse Health | Not published | Not published | Not published | Not published |
When a competitor is the right answer
This is the part most vendor comparisons omit, which is why most vendor comparisons are not worth reading.
- Choose Bask Health if SOC 2 Type II is a procurement gate, or you have an engineering team that will genuinely build on the developer surface. PharmaBro does not hold SOC 2 Type II.
- Choose OpenLoop if you want medication and lab costs, merchant reserves and clinical operations off your balance sheet. That is a real transfer of working capital and risk, and roughly half of patient revenue is an honest price for it.
- Choose Cuvo if you want to be a brand owner rather than an operator, and are content for the platform to run the clinic and hold billing.
- Choose Rimo if you are launching a single brand and value the longest operator track record in the flat-fee model.
- Choose CareValidate if you want chargeback handling fully outsourced and SOC 2 attestation, and the 3.9% processing rate is acceptable.
The pattern worth noticing
Four of the nine platforms above do not publish pricing. That is not an accident of web design.
A price you cannot see can be set after the vendor learns how badly you need it, and it prevents you modelling your own contribution margin before you commit. When half a category behaves this way, published pricing stops being a courtesy and becomes a differentiator.
What PharmaBro is actually for
An operator who buys their own traffic, wants the patient's money in an account with their own name on it, and intends to run more than one brand eventually.
Published pricing. Your own Stripe on every tier. Zero revenue share. Zero medication markup. Unlimited brands. No contract term. Live in 5 days.
Conclusion
There is no best platform in this category, only a best fit for a specific operator, and the honest version of this comparison names the cases where somebody else wins.
Ask all of them the same four questions in writing: the pricing model, the merchant of record, the launch timeline and the multi-brand terms. The willingness to answer in writing will separate your shortlist faster than any demo.
Frequently asked questions
What is the best white-label telehealth platform?
It depends on what you are optimising for, and this page is written by one of the platforms so treat its verdict accordingly. For flat-fee economics with brand-owned payments, PharmaBro or Rimo. For done-for-you operation, Cuvo. For enterprise procurement requiring SOC 2 Type II, Bask. For outsourced working capital, OpenLoop.
Why do so many telehealth platforms hide their pricing?
Because an undisclosed price can be set once the vendor understands your urgency, and because it prevents you modelling your unit economics before committing. Four of the nine platforms on this page do not publish pricing.
Does PharmaBro hold SOC 2 Type II?
No. Bask Health and CareValidate do. If SOC 2 attestation is a hard requirement for your buyer or your procurement process, that is a legitimate reason to choose one of them instead, and we would rather say so here than have you find out later.
References
- 1.Cuvo published pricing
- 2.Rimo published pricing
- 3.CareValidate, Telehealth Platform Pricing Deck 2026
- 4.OpenLoop, Summary of Proposed Services, 05.28.26
- 5.PharmaBro published pricing
Every figure above is sourced and dated. If you represent one of the platforms named here and something is out of date or wrong, write to support@pharmabro.co and we will correct it and note the change on the page.
Anmol SethiFounder
Ran direct-to-consumer telehealth brands and paid a revenue share on every dollar they earned. Built PharmaBro as the infrastructure he wanted to buy.